Bioline Rx's total assets for Q4 2025 were $40.91M, an increase of 2.79% from the previous quarter. IL:BLRX total liabilities were $17.56M for the fiscal quarter, a -13.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.